PHRRF (PharmaTher Holdings) Buyback Yield %: 0.00 (As of Jul. 07, 2026)


What is PharmaTher Holdings Buyback Yield %?

PharmaTher Holdings PHRRF -4.87% Buyback Yield % is 0.00 as of Jul. 07, 2026. The stock has 2 warning signs investors should review. Among 740 Biotechnology companies, PharmaTher Holdings ranks worse than 135135% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

PharmaTher Holdings's current buyback yield was 0.00%.

PharmaTher Holdings Buyback Yield % Historical Data

* Premium members only.

The historical data trend for PharmaTher Holdings's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaTher Holdings Buyback Yield % Chart

PharmaTher Holdings Annual Data
Trend May21 May22 May23 May24 May25
Buyback Yield %
-5.68 -67.79 0.00 0.00 0.00

PharmaTher Holdings Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

PHRRF vs VRTX, REGN, ALNY: Buyback Yield % Comparison

For the Biotechnology subindustry, PharmaTher Holdings's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PharmaTher Holdings Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PharmaTher Holdings's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where PharmaTher Holdings's Buyback Yield % falls into.


PharmaTher Holdings Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

PharmaTher Holdings's Buyback Yield for the fiscal year that ended in May. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 0) / 13.366369
=0.00%

PharmaTher Holdings's annualized Buyback Yield for the quarter that ended in Feb. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 0) / 4.80762358
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of 0.00 mean?
PharmaTher Holdings (PHRRF) has a Buyback Yield % of 0.00 as of Jul. 07, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on PharmaTher Holdings and its competitors. According to the industry distribution chart, PharmaTher Holdings ranks #999999 out of 740 companies in the Biotechnology industry.
Is PharmaTher Holdings' Buyback Yield % too high?
PharmaTher Holdings' current Buyback Yield % is 0.00. Based on the distribution chart, PharmaTher Holdings ranks #999999 out of 740 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does PharmaTher Holdings' Buyback Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, PharmaTher Holdings ranks #999999 out of 740 companies for Buyback Yield %. This places PharmaTher Holdings in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on PharmaTher Holdings and its competitors. PharmaTher Holdings's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaTher Holdings stock overvalued right now?
PharmaTher Holdings (PHRRF) has a current Buyback Yield % of 0.00. The current Buyback Yield % is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For PharmaTher Holdings (PHRRF), the current Buyback Yield % is 0.00 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PharmaTher Holdings Business Description

Other Exchanges NCC0:GermanyPHRM:Canada
Address 82 Richmond Street East, Toronto, ON, CAN, M5C 1P1
PharmaTher Holdings Ltd is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals for FDA approval to treat mental health, neurological, and pain disorders. Its product pipeline includes Ketamine, KETABET, Microneedle Patch and others.